64P - Clinical profile and treatment outcome of patients with non-metastatic colon cancer: A single institutional study from India

Background

Colo rectal cancer is the third most common cancer in the world. Clinical data on localized colon cancer and treatment outcome is scarce in the literature. This is a real-world study of the clinical profile and treatment patterns and outcomes of patients with nonmetastatic colon cancer from India. Here we report our experience in this patient population.

Methods

This is a retrospective chart review of patients with nonmetastatic colon cancer registered in our hospital from May 2011 to December 2021. Patients who presented with recurrent metastatic disease were included in this review if the treatment details for the localized disease were available. The baseline demographic features and treatment details and toxicity were recorded.

Results

Total of 1084 patients were registered during this time period. The median age of the population was 60 (9-91 )years. Males constituted 648 (60%) of cases. The most common site of the primary was descending and sigmoid colon (41%). Majority of the patients had stage III disease (46.5%). Most of our patients received capecitabine and oxaliplatin-based combination therapy. The median disease-free survival is 30.7 months.

Conclusions

Most common site of colon cancer is the left side and stage III is the most common stage of presentation.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.